Lucid Diagnostics Inc. (LUCD)
LUCD trades on Nasdaq in Health Care, Medical/Dental Instruments. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/1799011/000143774926009805/0001437749-26-009805-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.
Profile
| Field | Value |
|---|---|
| Ticker | LUCD on Nasdaq |
| Sector | Health Care |
| Industry | Medical/Dental Instruments |
| Country | United States |
| IPO year | 2021 |
| SEC CIK | 0001799011 |
| SEC industry code | Surgical & Medical Instruments & Apparatus |
| Incorporated in | DE |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $4.7M |
| Net income | -$58.0M |
| Operating income | -$49.6M |
| Net margin | -1232.7% |
| Operating margin | -1054.8% |
| Revenue growth | +8.3% |
| Cash | $34.7M |
| Total assets | $40.4M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 17.5× |
Warning signs
| Sign | Finding | Source |
|---|---|---|
| Going concern | States substantial doubt about continuing as a going concern. "These factors raise substantial doubt about the Company's ability to continue as a going concern within one year after the date the accompanying unaudited condensed consolidated financial statements are issued." | 10-Q 2026-11-12 |
| Cash and burn | $18.0M cash; operating cash flow -$12.9M a quarter. | Report 2026-09-30 |
| Shares outstanding | 206,977,800 (2026-11-10); 137,508,926 a year earlier; 44,667,304 three years earlier. | Cover page 2026-11-10 |
| Reverse splits, 3 years | None found | None on EDGAR |
| Shelf and offerings, 12 months | 1 S-3/F-3 shelf filings; 2 424B5 takedowns, 2 at the market | Latest 2026-04-23 |
| Exchange deficiency notices, 12 months | 1 (8-K item 3.01) | 8-K 2026-10-16 |
| Auditor | CBIZ CPAs P.C., New York, New York, United States; changed auditors 1 time in 24 months | 8-K 4.01 2025-04-25 |
| Late filings, 12 months | None | None on EDGAR |
| Insider trades, 12 months | Bought $245K, sold $0 on the open market | SEC Forms 3/4/5 data sets 2026-09-30 |
From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.
Quarterly results
| Quarter | Revenue | Net income | Op. cash flow | Cash | Total debt | TTM revenue | Source |
|---|---|---|---|---|---|---|---|
| Q3 2026 2026-09-30 | $1.2M | -$6.7M | -$15.6M | $18.0M | $17.3M | $5.4M | 10-Q 2026-11-12 |
| Q2 2026 2026-06-30 | $1.5M | -$11.7M | -$11.3M | $33.4M | $23.5M | $5.4M | 10-Q 2026-08-12 |
| Q1 2026 2026-03-31 | $1.3M | -$13.9M | -$12.1M | $27.9M | $25.2M | $5.1M | 10-Q 2026-05-13 |
| Q4 2025 2025-12-31 | $1.5M | -$16.3M | -$12.6M | $34.7M | $24.0M | $4.7M | 10-K 2026-03-25 |
| Q3 2025 2025-09-30 | $1.2M | -$10.4M | -$10.9M | $47.3M | $22.3M | $4.4M | 10-Q 2025-11-12 |
| Q2 2025 2025-06-30 | $1.2M | -$4.4M | -$10.5M | $31.1M | $25.3M | $4.4M | 10-Q 2025-08-12 |
| Q1 2025 2025-03-31 | $828K | -$26.9M | -$12.5M | $25.2M | $32.8M | $4.2M | 10-Q 2025-05-13 |
| Q4 2024 2024-12-31 | $1.2M | -$11.5M | -$9.9M | $22.4M | $18.6M | $4.3M | 10-K 2025-03-24 |
From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B5 | 2026-04-23 |
| Latest annual report FORM 10-K | 10-K | 2026-03-25 |
| Latest quarterly / interim FORM 10-Q | 10-Q | 2026-11-12 |
| Latest current report | 8-K | 2026-11-12 |
| Latest proxy | DEFA14A | 2026-04-30 |
Source: SEC EDGAR submissions feed, 283 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | +12.8% |
| 1 month | -25.9% |
| 3 months | -53.5% |
| Year to date | -58.8% |
| 1 year | -58.0% |
| From 52-week high | -69.5% |
Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Medical/Dental Instruments
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| NYXH | Nyxoah SA | $0.8937 | -0.64% | $89.4M |
| SKIN | SkinHealth Systems Inc. | $15.05 | -7.73% | $98.5M |
| LNSR | LENSAR Inc. | $5.29 | +5.80% | $65.0M |
| QTEX | QTREX Quantum Ltd. | $1.15 | -8.00% | $64.4M |
| SKYA | SkyAI Inc. | $2.11 | -9.05% | $107.3M |
| APYX | Apyx Medical Corporation | $2.65 | -5.69% | $111.6M |
| STIM | Neuronetics Inc. | $1.25 | -10.07% | $120.6M |
| LUNG | Pulmonx Corporation | $2.80 | -2.10% | $121.9M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier